James M. Meer - 01 Mar 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for James M. Meer
Issuer symbol
ELAN
Transactions as of
01 Mar 2023
Net transactions value
-$11,409
Form type
4
Filing time
03 Mar 2023, 19:58:23 UTC
Previous filing
05 Jan 2023
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Tax liability $7,578 -673 -3.6% $11.26 18,243 01 Mar 2023 Direct F1
transaction ELAN Common Stock Award $0 +8,659 +47% $0.000000 26,902 01 Mar 2023 Direct F2
transaction ELAN Common Stock Tax liability $3,831 -348 -1.3% $11.01 26,554 02 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F2 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.